Brief: Tianjin Teda Biomedical Engineering To Purchase All Shares In Shanghai Weidi For Rmb12.8 Mln
18/07/2022 13:18
July 18 (Reuters) - Tianjin TEDA Biomedical Engineering Co
Ltd 8189.HK :
* CO TO PURCHASE ALL SHARES IN SHANGHAI WEIDI AT A
CONSIDERATION
OF RMB12.8 MILLION
Source text for Eikon: ID:nHKSc5vPHX
Further company coverage: 8189.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Teda Biomedical Engineering Co
See all newsBrief: Tianjin Teda Biomedical Engineering Appoints Lynn Li As Joint CEO, Re-Designates Sun Li As Joint CEO
Brief: Tianjin Teda Biomedical Engineering Signs AI Healthcare Cooperation Agreement
Brief: Tianjin Teda Biomedical Engineering Says Unit Enters Strategic Cooperation
Brief: Tianjin Teda Biomedical Engineering Says Zhongtai International Securities To Procure Placees
Brief: Tianjin Teda Biomedical Engineering Says Re-Designation Of He Xin To Non-Executive Director